Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/21614153

Download in:

View as

General Info

PMID
21614153